Welcome!
IMS Divisions
Broker's Calls
Resilient through FY20, recent correction presents a 'buying opportunity' for Frencken: RHB
"We believe FY2021 will be a strong year for the group, where both its semiconductor and medical segments should drive profits."
March 10, 2021